开心散加味通过干预肠道菌群及其代谢物改善APP/PS1小鼠认知功能障碍
该研究以3月龄APP/PS1转基因小鼠为对象,设模型组、多奈哌齐组、开心散加味低/中/高剂量组及野生型对照组,灌胃给药2个月。结果提示开心散加味可改善学习记忆、减少脑内淀粉样沉积,恢复肠道菌群平衡(以厚壁菌门及丁酸为代表)、修复肠屏障并调节肠肽激素,可能经脑肠轴多环节干预AD。
要点
- 开心散加味可改善AD模型小鼠学习记忆并减少脑内淀粉样沉积。
- 其作用与恢复肠道菌群平衡、调节丁酸等代谢物及肠屏障功能相关。
- 研究支持中药经脑肠轴多环节干预阿尔茨海默病的思路。
核心结论
- 开心散加味可能通过调节肠道微生物及其代谢物改善AD模型小鼠的肠道内环境稳态,进而改善认知功能障碍。
- 中药具有通过脑肠轴多层面交互干预阿尔茨海默病的潜力。
研究设计与样本
- 研究将50只3月龄APP/PS1转基因小鼠随机分为5组(每组n=10):模型组、多奈哌齐组、开心散加味低/中/高剂量组。
- 另随机选取10只3月龄C57BL/6J野生型小鼠作为对照组。
- 对照组与模型组灌胃生理盐水,多奈哌齐组给予多奈哌齐0.92 mg/kg/d,开心散加味低/中/高剂量组给予提取物0.9/1.8/3.6 mL/kg/d,每日1次,连续2个月。
- 采用Morris水迷宫评价学习认知能力,HE染色评估结肠组织病理,16S rRNA测序分析肠道菌群,GC-MS检测短链脂肪酸含量。
- 通过免疫组化和Western blot检测结肠屏障完整性,评估脑组织β-淀粉样沉积,ELISA测定血清肠肽激素(胰高血糖素、GHRP-Ghrelin)。
主要发现
- 开心散加味增强了AD模型小鼠的学习能力和记忆,并减少了脑组织中的淀粉样沉积。
- 开心散加味恢复了肠道菌群平衡并调节菌群代谢物浓度,尤其以厚壁菌门及其主要代谢物丁酸为代表。
- 开心散加味恢复了肠道屏障功能,并改善了AD模型小鼠肠肽激素(胰高血糖素、GHRP-Ghrelin)的释放水平。
临床怎么用
- 该研究为开心散加味治疗阿尔茨海默病提供了动物实验依据,提示其作用与调节肠道菌群及代谢物有关。
- 临床可关注中药复方通过脑肠轴干预AD的潜在价值,但具体应用需结合临床证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alzheimer's disease (AD) is a degenerative disease of the central nervous system characterized by progressive cognitive impairment and memory loss. Chinese medicine's therapeutic effect on AD has become a promising treatment option in recent years, and the Chinese herbal compound Kai Xin San-Jia Wei (KXSJW) is one of its representatives. This study employed a comprehensive approach, including 16S rRNA and Gaschromatography-mass spectrometry (GC-MS) analysis, to investigate the therapeutic efficacy and intrinsic mechanism of KXSJW on AD. METHODS: 50 3-month-old APPswe/PS1dE9 transgenic mice were randomly divided into 5 groups (n = 10): model group (M), donepezil group (Don), KXSJW-low dose group (KJW-L), KXSJW- medium dose group (KJW-M), KXSJW-high dose group (KJW-H), Ten 3-month-old C57BL/6 J wild-type mice were randomly selected as the control group (C). The control and model groups were administered saline by gavage, the donepezil group was administered donepezil (0.92 mg/kg/d), and the KXSJW-low/medium/high dose group was administered KXSJW extract (0.9/1.8/3.6 mL/kg/d); each group was treated once daily for 2 months. The study employed the Morris Water Maze (MWM) to evaluate learning and cognitive abilities. Pathological changes in colon tissue were assessed through hematoxylin and eosin (HE) staining. Analysis of gut microbiota was conducted using 16S rRNA sequencing, and gut microbial metabolite (short chain fatty acids, SCFAs) content was detected using GC-MS. Colonic tissue barrier integrity was examined through immunohistochemistry and western blot, while β-amyloid deposition in brain tissue was assessed. ELISA was used to measure serum intestinal peptide hormones (Glucagon, GHRP-Ghrelin). RESULTS: KXSJW enhanced learning ability and memory, reduced amyloid deposition in the brain tissue of AD model mice. KXSJW was able to restore the balance of intestinal flora and regulate the concentration of intestinal flora metabolites, especially represented by Firmicutes and its major metabolite butyric acid. Meanwhile, KXSJW restored the intestinal barrier function and improved the release level of intestinal peptide hormones (Glucagon, GHRP-Ghrelin) in AD model mice. This indicates that KXSJW can improve the intestinal internal environment of AD model mice. CONCLUSION: KXSJW may improve the homeostasis of the gut environment in AD, with a focus on the regulation of gut microorganisms and their metabolites, and subsequently improve cognitive impairment in AD. Traditional Chinese Medicine (TCM) has the potential to intervene in AD through multilevel interaction with the brain-gut-axis.
引用
- Mana L, Chen F, Yuan X, et al. KaiXinSan-JiaWei ameliorates cognitive dysfunction in APP/PS1 mice by intervening in gut microbiota and its metabolites. Front Pharmacol. 2025. PMID: 40351411. doi:10.3389/fphar.2025.1483883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。